Member Info for Livedataaccount

It's not going in the right direction! Come on Avacta, lets get some momentum.

Bring in a big investor at least

Touk, I don't get where you are coming from at all.

The 3 weekly dose showed remarkable safety and therefore they decided that it should be tried at 2 weekly, probably at lower dose and for longer as there are less side affects.

Why dont you email Alan or Chris and just ask directly?

No one here really knows what is going on more than you.

Just saying it as it is, potty mouth.

I think potential institution investors are quite savvy when it comes to an RNS. And have a lot of potential game changing, transformational aim companies not to say Avacta won't come good. I don't like their comms style.

This is part of my frustration.

The language used in RNS'S and by company staff - paradigm, game changing, pivotal, transformative.. Beginning of value curve.

Then comments like, we don't boost the share price, intimating at shareholder meetings the company is overvalued to get funding. Chucking when asked about future fundraising.

Respectfully, Buena. One hopes the management team at Avacta knows what's coming. It's their job to.

Avacta is now down 30 percent since the the CEOs we are at the beginning of the value curve comment. Thats nearly a third of the company.

Does anyone knw if this has actually started yet?

Actually heard anything from the company? It's a long time since avacta announced theyb ere screening. Not conjecture about how hard it is to find patients etc

Phase eleven or 2

Most of us have will be dead if this goes to eleven!

Yep, quarterly operational updates. Broken n down into Therapeutics, dx, affyxell etc. No need for the Vox markets interviews etc. May come across more professional.

That would be too straightforward

Perhaps it's a one hour discussion on the value curve?

Would exactly is likely to find out?

They won't come on funding, partnerships or anything price sensitive

I'm neutral about it. Does all seem to be a merry go round with Avacta and the AIM market.

Avacta don't help with there timescales and somewhat ambiguous RNS's.

How you read anything into how she left the company from that linkedin post is beyond me. Im sure she did leave amicably but no one knows amd frankly who cares.

Same as posting quotes from the rns for new employees joining the company. They are hardly going to wite "excited to be here, was between jobs and Avacta are paying me 250k a year, so I'll give it a good go".

It's all PR.

She sounds like a woman who liked her colleagues.

Icecool, I think your original post was simply trying to give reasons or justify why the Arm 2 hasn't started? Or at least not to the investment communities knowledge. Maybe it has? Who knows.

the Arm 2 trial isnt exclusive to first line treatment sufferers, so can put that to bed.

Whats going on with Arm 2? Has anyone been dosed yet?

Are you referring to the value curve, watching?

No, I will continue to challenge Avacta, their timelines and the CEO comments. It may not fit the bulletin board positive echo chamber but I find it is good to challenge investments. And can help with investment decisions when you are positive long term. Most recent being the CEO stating Avacta are at the start of a value curve and the SP tanks 35 percent. Can you imagine a ftse 100 CEO saying that? If Avacta want to build into a billion pound company they need to up their game with comms.

Has Avacta now hit the bottom of the value curve and will return to former glories!?